Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation. (Q49628505)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 November 2017
edit
Language Label Description Also known as
English
Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation.
scientific article published on 27 November 2017

    Statements

    Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit